Prevention and treatment of venous thromboembolism with low-molecular-weight heparins: Clinical implications of the recent European guidelines

Thrombosis Journal

Volumn 6, Issue , 2008, Pages

  Prandoni, Paolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; DALTEPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

BLEEDING; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COMPRESSION GARMENT; CONSENSUS DEVELOPMENT; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; DRUG USE; EUROPE; HIGH RISK PATIENT; HUMAN; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; LOW DRUG DOSE; LUNG EMBOLISM; MEDICAL SOCIETY; MORBIDITY; MORTALITY; ORTHOPEDIC SURGERY; POSTOPERATIVE THROMBOSIS; PRACTICE GUIDELINE; PRIMARY PREVENTION; RECURRENCE RISK; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURGICAL PATIENT; VENOUS THROMBOEMBOLISM;

EID: 52749085172     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-6-13     Document Type: Review

References (43)

1. Rubinstein I Murray D Hoffstein V Fatal pulmonary emboli in hospitalized patients. An autopsy study Arch Intern Med 1988, 148:1425-1426 10.1001/ archinte.148.6.1425 3377625
2. Karwinski B Svendsen E Comparison of clinical and postmortem diagnosis of pulmonary embolism J Clin Pathol 1989, 42:135-139 1141815 2921354 10.1136/jcp.42.2.135
3. Stein PD Henry JW Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy Chest 1995, 108:978-981 10.1378/ chest.108.4.978 7555172
4. Ryu JH Olson EJ Pellikka PA Clinical recognition of pulmonary embolism: problem of unrecognized and asymptomatic cases Mayo Clin Proc 1998, 73:873-879 9737225
5. Sandler DA Martin JF Autopsy proven pulmonary embolism in hospital patients: Are we detecting enough deep vein thrombosis? J R Soc Med 1989, 82:203-205 1292084 2716016
6. Cohen AT Alikhan R Arcelus JI Bergmann JF Haas S Merli GJ Spyropoulos AC Tapson VF Turpie AG Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients Thromb Haemost 2005, 94:750-759 16270626
7. Büller HR Agnelli G Hull RD Hyers TM Prins MH Raskob GE Antithrombotic therapy for venous thromboembolic disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 2004, 126:401-4228S 10.1378/chest.126.3_suppl.401S
8. Bergqvist D Jendteg S Johansen L Persson U Odegaard K Cost of long-term complications of deep venous thrombosis of the lower extremities: An analysis of a defined patient population in Sweden Ann Intern Med 1997, 126:454-457 9072931
9. Kahn SR Hirsch A Shrier I Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis Arch Intern Med 2002, 162:1144-1148 10.1001/archinte.162.10.1144 12020185
10. Pengo V Lensing AW Prins MH Marchiori A Davidson BL Tiozzo F Albanese P Biasiolo A Pegoraro C Iliceto S Prandoni P Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism N Engl J Med 2004, 350:2257-2264 10.1056/NEJMoa032274 15163775
11. Mismetti P Laporte S Darmon JY Buchmuller A Decousus H Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery Br J Surg 2001, 88:913-930 10.1046/ j.0007-1323.2001.01800.x 11442521
12. Geerts WH Bergqvist D Pineo GF Heit JA Samama CM Lassen MR Colwell CW Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 2008, 133(6 Suppl):381S-453S 10.1378/chest.08-0656 18574271
13. Nicolaides AN Fareed J Kakkar AK Breddin HK Goldhaber SZ Hull R Kakkar VV Michiels JJ Myers K Samama M Sasahara A Kalodiki E Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence Int Angiol 2006, 25:101-161 16763532
14. Goldhaber SZ Dunn K MacDougall RC New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatment Chest 2000, 118:1680-1684 10.1378/chest.118.6.1680 11115458
15. Ageno W Grimwood R Limbiati S Dentali F Steidl L Wells PS Home-treatment of deep vein thrombosis in patients with cancer Haematologica 2005, 90:220-224 15710575
16. Kakkar AK Levine M Pinedo HM Wolff R Wong J Venous thrombosis in cancer patients: Insights from the FRONTLINE survey Oncologist 2003, 8:381-388 10.1634/theoncologist.8-4-381 12897335
17. Kirwan CC Nath E Byrne GJ McCollum CN Prophylaxis for venous thromboembolism during treatment for cancer: Questionnaire survey Br Med J 2003, 327:597-598 10.1136/bmj.327.7415.597
18. Chopard P Dörffler-Melly J Hess U Wuillemin WA Hayoz D Gallino A Bachli EB Canova CR Isenegger J Rubino R Bounameaux H Venous thromboembolism prophylaxis in acutely ill medical patients: Definite need for improvement J Intern Med 2005, 257:352-357 15788005
19. Eikelboom JW Quinlan DJ Douketis JD Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: A meta-analysis of the randomised trials Lancet 2001, 358:9-15 10.1016/ S0140-6736(00)05249-1 11454370
20. Vaitkus PT Leizorovicz A Cohen AT Turpie AGG Olsson CG Goldhaber SZ Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients Thromb Haemost 2005, 93:76-79 15630494
21. Heit JA Silverstein MD Mohr DN Petterson TM O'Fallon WM Melton LJ Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study Arch Intern Med 2000, 160:809-815 10.1001/archinte.160.6.809 10737280
22. Donati MB Cancer and thrombosis Haemostasis 1994, 24:128-131 7959360
23. Falanga A Zacharski L Deep vein thrombosis in cancer: The scale of the problem and approaches to management Ann Oncol 2005, 16:696-701 10.1093/ annonc/mdi165 15802275
24. Otten HM Mathijssen J ten Cate H Soesan M Inghels M Richel DJ Prins MH Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: An underestimated phenomenon Arch Intern Med 2004, 164:190-194 10.1001/archinte.164.2.190 14744843
25. Hiller E Cancer and thrombosis: Managing the risks and approaches to thromboprophylaxis Onkologie 2006, 29:474-478 10.1159/000095484 17028457
26. van Dongen CJ Belt van den AG Prins MH Lensing AW Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism Cochrane Database Syst Rev 2004, 4 CD001100 15495007
27. Segal JB Streiff MB Hofmann LV Thornton K Bass EB Management of venous thromboembolism: A systematic review for a practice guideline Ann Intern Med 2007, 146:211-222 17261856
28. Kearon C Kahn SR Agnelli G Goldhaber S Raskob GE Comerota AJ Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 2008, 133(6 Suppl):454S-545S 10.1378/chest.08-0658 18574272
29. The Matisse Investigators Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism N Engl J Med 2003, 349:1695-1702 10.1056/NEJMoa035451 14585937
30. Büller HR Davidson BL Decousus H Gallus A Gent M Piovella F Prins MH Raskob G Segers AEM Cariou R Leeuvenkamp O Lensing AWA Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: A randomized trial Ann Intern Med 2004, 140:867-873 15172900
31. Ageno W Squizzato A Ambrosini F Dentali F Marchesi C Mera V Steidl L Venco A Thrombosis prophylaxis in medical patients: A retrospective review of clinical practice patterns Haematologica 2002, 87:746-750 12091126
32. Siragusa S Arcara C Malato A Anastasio R Valerio MR Fulfaro F Lo Coco L Grimaudo S Bajardi G Abbadessa V Gebbia N Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients Ann Oncol 2005, 16(suppl 4):iV136-139 15923414 10.1093/annonc/mdi923
33. Lee AYY Levine MN Baker RI Bowden C Kakkar AK Prins M Rickles FR Julian JA Haley S Kovacs MJ Gent M Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer N Engl J Med 2003, 349:146-153 10.1056/NEJMoa025313 12853587
34. Nightingale SL From the Food and Drug Administration. Appropriate use of low-molecular-weight heparins (LMWHs) JAMA 1993, 270:1672 10.1001/ jama.270.14.1672 8411485
35. Wells PS Anderson DR Rodger MA Forgie MA Florack P Touchie D Morrow B Gray L O'Rourke K Wells G Kovacs J Kovacs MJ A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism Arch Intern Med 2005, 165:733-738 10.1001/archinte.165.7.733 15824291
36. Planès A Samama MM Lensing AW Büller HR Barre J Vochelle N Beau B Prevention of deep vein thrombosis after hip replacement: comparison between two low-molecular heparins, tinzaparin and enoxaparin Thromb Haemost 1999, 81:22-25 10348714
37. Planès A Vochelle N Fagola M Bellaud M Comparison of two low-molecular-weight heparins for the prevention of postoperative venous thromboembolism after elective hip surgery Blood Coag Fibrinol 1998, 9:499-505 10.1097/00001721-199809000-00007
38. TIFDED Study Group Thromboprophylaxis in hip fracture surgery: A pilot study comparing danaparoid, enoxaparin and dalteparin Haemostasis 1999, 29:310-317 10.1159/000022518 10844404
39. Navarro-Quilis A Castellet E Rocha E Paz-Jimenez J Planès A Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: A randomized, double-blind clinical trial J Thromb Haemost 2003, 1:425-432 10.1046/j.1538-7836.2003.00142.x 12871445
40. Caprini JA Hyers TM Compliance with antithrombotic guidelines: Current practice, barriers, and strategies for improvement Manag Care 2006, 15:49-50 17036939
41. Caprini JA Arcelus JI Reyna JJ Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease Semin Hematol 2001, 38(2 suppl 5):12-19 10.1016/S0037-1963(01)90094-0 11449339
42. Samama MM Dahl OE Mismetti P Quinlan DJ Rosencher N Cornelis M de Vries H van Beusekom I Kahan JP An electronic tool for venous thromboembolism prevention in medical and surgical patients Haematologica 2006, 91:64-70 16434372
43. Kucher N Koo S Quiroz R Cooper JM Paterno MD Soukonnikov B Goldhaber SZ Electronic alerts to prevent venous thromboembolism among hospitalized patients N Engl J Med 2005, 352:969-977 10.1056/NEJMoa041533 15758007